Life Science & Biotech

Profs trying to revolutionize drug discovery processRestricted Content

June 22, 2009
 IBJ Staff
Two chemistry professors at IUPUI are laboring to create the McDonald's of research laboratories—a model that's low-cost and can spread around the world.
More

Bioanalytical Systems founder fights to be heardRestricted Content

May 4, 2009
Peter Schnitzler
It took Pete and Candace Kissinger 33 years to build West Lafayette-based Bioanalytical Systems Inc. into one of the largest contract research firms in Indiana's life science sector. It took just a year and a half for them to turn against the company's new management.
More

With pharma famine looming, Lilly relying on snack-size dealsRestricted Content

May 4, 2009
J.K. Wall
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
More

Stem cell discovery promises health care revolutionRestricted Content

April 13, 2009
Bloomberg News
Scientists are using a new stem-cell technique that may someday revolutionize care for disorders as diverse as diabetes, Alzheimer's disease and muscular dystrophy.
More

Indiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individualsRestricted Content

April 13, 2009
Chris O'Malley
Indiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to use it on the practitioner level.
More

Linking specialties is key to life sciencesRestricted Content

March 30, 2009
The Indiana Innovation Alliance will bring together researchers from both IU and Purdue and keep much intellectual property innovation in Indiana.
More

Executives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cellsRestricted Content

March 23, 2009
J.K. Wall
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells.
More

Medical, tech entrepreneurs launch matchmaking effort in life sciencesRestricted Content

March 16, 2009
Chris O'Malley
Three entrepreneurs from the medical and software realms are herding angels to invest in upstart life sciences companies in Indiana.
More

Attorneys with doctorates in high demandRestricted Content

March 16, 2009
Scott Olson
Lawyers holding doctorates in biotech, biology, chemistry and computer sciences are in high demand by firms with strong intellectual property practices.
More

Dow may need to sell Indy's Dow AgroSciencesRestricted Content

February 16, 2009
Peter Schnitzler
Financially strapped Dow Chemical Co. acknowledges it may sell Indianapolis-based Dow AgroSciences LLC, the ag-chemicals-and-biotech firm that's one of the biggest jewels in the city's life sciences crown.
More

Advanced energy next focus for economic developmentRestricted Content

February 16, 2009
Chris O'Malley
The Central Indiana Corporate Partnership—the parent of the BioCrossroads, TechPoint and Conexus industry cluster initiatives—let it be known last month that there would be a fourth leg to its economic development stool: clean technology.
More

NASA contracts soaringRestricted Content

February 9, 2009
Chris O'Malley
NASA begins to award more grants to Indiana firms and universities.
More

Biotech push may help offset generic competition; some analysts skepticalRestricted Content

February 2, 2009
J.K. Wall
Lilly executives want to make biotech their top focus.
More

Carmel startup lands $12M in venture capitalRestricted Content

January 19, 2009
Peter Schnitzler
Carmel startup Waterstone Pharmaceuticals Inc., which hopes to research drug components here and make them in China, has just raised $12 million in venture capital—despite the recession and a deep freeze in financial markets.
More

OBS Medical hopes to capture pharma's heartRestricted Content

January 19, 2009
J.K. Wall
The latest product to come out of Carmel-based OBS Medical may be just what the doctors ordered. The doctors working for major pharmaceutical companies, that is.
More

Grants will shrink, life sciences leader predictsRestricted Content

January 19, 2009
Scott Olson
Last fall, BioCrossroads named Leonard J. Betley—chairman of the Richard M. Fairbanks Foundation, the Regenstrief Foundation and the Walther Cancer Foundation—its inaugural Life Sciences Champion of the Year. IBJ recently caught up with Betley to get his thoughts on the latest life sciences developments and gauge the climate for fund raising.
More

Targanta receives rescue line for drugRestricted Content

January 19, 2009
A former Eli Lilly and Co. antibiotic being developed in Indianapolis will live to try again. The company developing the drug, Massachusetts-based Targanta Therapeutics Inc., has agreed to be acquired by New Jersey-based The Medicines Co. for $42 million.
More

State's tech sector looking ahead, but cutting backRestricted Content

January 12, 2009
It's two steps forward, one step back, for Indiana's technology sector, but in a tough economic climate, any advancement is worth celebrating.
More

Biotech venture fund in worksRestricted Content

January 5, 2009
Peter Schnitzler
BioCrossroads is setting the stage to create Indiana Future Fund II, an effort that would raise tens of millions of dollars for speculation on promising Hoosier life science companies.
More

Lilly eyes generic biotech drugsRestricted Content

January 5, 2009
Generic drugmakers have been the nemesis of companies like Eli Lilly and Co., but now the Indianapolis-based company and its peers want to get in the generic game themselves.
More

Lilly makes $6.5B acquisitionRestricted Content

December 29, 2008
J.K. Wall
Eli Lilly and Co. CEO John Lechleiter played a game of pharmaceutical poker with former Lilly Chief Financial Officer Jim Cornelius—and won.
More

Firm off to a FAST start: Investors backing company's kidney assessment technologyRestricted Content

October 6, 2008
Scott Olson
FAST Diagnostics quickly is becoming one of the more promising companies in Indiana University's efforts to commercialize its discoveries. Incorporated in November 2006, it is developing a method to measure kidney function faster and more accurately than existing techniques can. While FAST represents speed, the name actually stands for functional assessment and surveillance technology. The fledgling firm so far has attracted more than $4 million from investors, including $2 million from the state's 21st Century Fund. BioCrossroads, Rose Hulman Ventures...
More

VOICES FROM THE INDUSTRY: Avoid a royalty mess by reviewing your patent licenseRestricted Content

October 6, 2008
Lynn C.
The U.S. Supreme Court's recent decision in Quanta Computer v. LG Electronics left LG stuck in "a royalty mess" that should inspire local businesses to review their patent licenses. More specifically, the decision raises important questions about the extent to which-and the cir cumstances under which-patent owners can collect royalties from more than one party in the distribution chain. Although the case arose out of the IT industry, its lessons could significantly impact Indiana life sciences companies. Collecting downstream In...
More

IU makes plans to hatch more businesses: Incubator in Bloomington hopes to duplicate success of local Emerging Technologies CenterRestricted Content

October 6, 2008
Scott Olson
Ground should be broken late this month or in early November, with completion expected by summer. Cost of the 40,000-square-foot facility-4,000 square feet smaller than the one here-is estimated in the $8 million to $10 million range. While it may be a bit smaller in size, the scope is broader. The new incubator will promote both life sciences companies and information technology firms. That goal differs from the mission of the existing IU Emerging Technologies Center on 10th Street, which...
More

Arcadia banking on DailyMed: Company hopes product sales can help it escape debt, lift stockRestricted Content

October 6, 2008
Peter Schnitzler
When Arcadia Resources Inc. moved from Southfield, Mich., to Indianapolis last fall, the Indiana Economic Development Corp. crowed with pride. In exchange for incentives worth more than $6 million, the state had landed the headquarters of a publicly traded life sciences firm with more than 5,000 employees. Even better, the company was ready to launch an innovative new product that promises to improve home health care while simultaneously reducing its cost. A year has passed, but investors still aren't as...
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Can your dog sign a marriage license or personally state that he wishes to join you in a legal union? If not then no, you cannot marry him. When you teach him to read, write, and speak a discernible language, then maybe you'll have a reasonable argument. Thanks for playing!

  2. Look no further than Mike Rowe, the former host of dirty jobs, who was also a classically trained singer.

  3. Current law states income taxes are paid to the county of residence not county of income source. The most likely scenario would be some alteration of the income tax distribution formula so money earned in Marion co. would go to Marion Co by residents of other counties would partially be distributed to Marion co. as opposed to now where the entirety is held by the resident's county.

  4. This is more same-old, same-old from a new generation of non-progressive 'progressives and fear mongers. One only needs to look at the economic havoc being experienced in California to understand the effect of drought on economies and people's lives. The same mindset in California turned a blind eye to the growth of population and water needs in California, defeating proposal after proposal to build reservoirs, improve water storage and delivery infrastructure...and the price now being paid for putting the demands of a raucous minority ahead of the needs of many. Some people never, never learn..

  5. I wonder if I can marry him too? Considering we are both males, wouldn't that be a same sex marriage as well? If they don't honor it, I'll scream discrimination just like all these people have....

ADVERTISEMENT